{"id":"tp-61355","type":"article-newspaper","title":"Chemomab Therapeutics Posts $5.1 Million Third-Quarter Net Loss","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/61355","datePublished":"2026-11-19T13:19:14.000Z","dateModified":"2026-11-19T13:19:14.000Z","language":"en","abstract":"The loss was less than $0.01 per basic and diluted ordinary share. Cash, cash equivalents and short-term bank deposits totaled $4.7 million as of Sept. 30, 2026.","section":"Business","references":[]}